Search
Grace Therapeutics, Inc
GRCEAdd to Watchlist
2.170USD
+0.010+0.46%
Market hours （ET）Quotes delayed by 15 min
35.31MMarket Cap
LossP/E TTM
GRCE Financials
See Grace Therapeutics, Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Grace Therapeutics, Inc Earnings Date
Latest Release
Aug 13, 2026
EPS / Forecast
-0.91/-0.13
Revenue / Forecast
--/0.00
Period
FY2026 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.47
40.37%
Analyst Rating
BUY
2026/08/16
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its current assets were 17.38M, with a year-on-year change of -23.48.
What are the total assets of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its total assets of Grace Therapeutics, Inc were 66.65M, with a year-on-year change of -7.42.
What are the total liabilities of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its total liabilities of Grace Therapeutics, Inc were 2.76M, with a year-on-year change of -48.76.
What is the total equity of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its total equity of Grace Therapeutics, Inc was 63.90M, with a year-on-year change of -4.07.
What is the net operating income of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its net operating income of Grace Therapeutics, Inc was -11.08M, with a year-on-year change of 33.59.
What is the net financing of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its net financing of Grace Therapeutics, Inc was 3.71M, with a year-on-year change of -73.54.
What is the Earnings Per Share (EPS) of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -0.47, with a year-on-year change of 40.37.
What is the net income of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its net income was -7.79M, with a year-on-year change of 18.55.
What is the Return on Equity (ROE) of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its Return on Equity (ROE) was -11.94, with a year-on-year change of 19.90.
What is the Return on Assets (ROA) of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its Return on Assets (ROA) was -11.24, with a year-on-year change of 14.65.
What is the operating profit of Grace Therapeutics, Inc?
According to Grace Therapeutics, Inc's FY2026 earnings report, its operating profit was -11.08M, with a year-on-year change of 33.59.